Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05702723

Building Resiliency Among Caregivers of Curvivors and Metavivors

Conditions: Stress, Cancer Diagnosis, Distress, Emotional

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 96
Sponsor: Massachusetts General Hospital

Location: United States

Summary

The main purpose of this research study is to assess the feasibility and participants' satisfaction of the Stress Management and Resiliency - Relaxation Response Resiliency Program (SMART-3RP) and compare this treatment with SMART-3RP versus referral to a group-based, online support group to see which is better for improving resilience and decreasing distress of participants with cancer and their caregivers.The name of the study intervention involved in this study is:Smart-3RP (virtual, mind-body group treatment program).

Eligibility Criteria

Inclusion Criteria for Patients:English speaking adult patients with cancer (18 years or older)Treated at MGH, who are either within approximately:3 months to 3 years after completing potentially curative therapy for cancer diagnosis including surgery, radiation, and/or chemotherapy or other novel therapies (e.g., immunotherapy, biological therapy). Patients can be on long- term maintenance hormonal or biological therapy at the time of enrollment.6 months to 3 years after diagnosis of metastatic disease with an expected prognosis of >1 year as confirmed by the treating oncology clinicianAble to identify a caregiver (i.e., spouse/partner or patient-identified family member or friend) who is willing to participate in the studyExclusion Criteria for Patients:Prognosis less than one year as determined by the treating oncology clinicianActive psychiatric or cognitive comorbidity that prohibits the capacity to provide informed consent as determined by the treating oncology clinicianPatients without a caregiver who is willing to participateInclusion Criteria for Caregivers:Adult caregiver (age 18 years or older).Identified by the patient as the spouse/partner or family member/friend.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05702723). StuddyBuddy aggregates publicly available trial information.